Corteva reported $17.8B of revenue over the trailing twelve months, +3.7% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $17.8B (to Q2 2026). Net income: $1.01B, trailing twelve months to Q2 2026. Free cash flow: $629M, trailing twelve months to Q2 2026. EPS: $1.52, trailing twelve months to Q2 2026.

CTVACorteva

Basic Materials

$77.67+7.9% 1Y

$77.67

$11.9252 weeks$89.97

CTVA as reported

Corteva reported $17.8B of revenue over the trailing twelve months, +3.7% on the year before. 9 reported series are charted on this page, each one as filed.

$17.8B

Revenue, trailing twelve months · to Q2 2026 · +3.7% against the twelve months before

Net income: $1.01B
Net income · −28% year on year · trailing twelve months to Q2 2026
Free cash flow: $629M
Free cash flow · −76% year on year · trailing twelve months to Q2 2026
EPS: $1.52
EPS · −26% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CTVA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$17.8B	+3.7%	Q2 2026
Net income	$1.01B	−28%	Q2 2026
EPS	$1.52	−26%	Q2 2026
Gross margin	47%	n/a	Q2 2026
Net margin	1.6%	n/a	Q2 2026
ROE	4.9%	n/a	Q2 2026
ROA	2.9%	n/a	Q2 2026
Free cash flow	$629M	−76%	Q2 2026
P/E	8.70	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.